AnaptysBio Announces Portfolio Update Across Best-in-Class Immune Cell Modulating Antibodies

Go back to AnaptysBio Announces Portfolio Update Across Best-in-Class Immune Cell Modulating Antibodies
(NASDAQ: ANAB) Delayed: 66.09 -0.5 (0.75%)
Previous Close $66.59    52 Week High
Open $66.55    52 Week Low
Day High $68.33    P/E N/A 
Day Low $63.50    EPS
Volume 191,935